US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Xenetic Biosciences Inc

17.54

0.0000

Volume:- -

Turnover:- -

Market Cap:65.67M

PE:-6.02

High:17.54

Open:17.54

Low:17.54

Close:17.54

52wk High:17.54

52wk Low:17.54

Shares:3.74M

Float Shares:2.66M

Volume Ratio:- -

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.9151

EPS(LYR):-9.6579

ROE:-55.77%

ROA:-24.91%

PB:5.70

PE(LYR):-1.82

Loading ...

Overview Company News Filings

Company Profile

Company Name:

Xenetic Biosciences Inc

Exchange:

NASDAQ

Establishment Date:

- -

Employees:

- -

Office Location:

- -

Website:

http://www.xeneticbio.com

Zip Code:

- -

Phone:

- -

Fax:

- -

Introduction:

Xenetic Biosciences, Inc., a biopharmaceutical company, focuses on advancing XCART, a personalized chimeric antigen receptor T cell (CAR T) platform technology engineered to target patient-specific tumor neoantigens. The company engages in the development of biologic drugs and therapeutics. It advances cell-based therapeutics targeting the B-cell receptor on the surface of an individual patient's malignant tumor cells for the treatment of B-cell lymphomas. In addition, the company leveraging PolyXen, its proprietary drug delivery platform, by partnering with biotechnology and pharmaceutical companies. It has collaboration agreements with Takeda Pharmaceutical Co. Ltd., Serum Institute of India Limited, and PJSC Pharmsynthez. Xenetic Biosciences, Inc. is headquartered in Framingham, Massachusetts.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/XBIOW/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"XBIOW","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XBIOW\",,,,,undefined,":{"symbol":"XBIOW","market":"US","secType":"STK","nameCN":"Xenetic Biosciences Inc","latestPrice":17.54,"timestamp":1772053200000,"preClose":17.54,"halted":0,"volume":0,"delay":0,"changeRate":0,"floatShares":2661762,"shares":3743889,"eps":-2.9151,"marketStatus":"Closed","change":0,"latestTime":"02-25 16:00:00 EST","open":17.54,"high":17.54,"low":17.54,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.9151,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1772096400000},"marketStatusCode":5,"adr":0,"exchange":"NASDAQ","adjPreClose":17.54,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XBIOW\",,,,,undefined,":{"symbol":"XBIOW","floatShares":2661762,"roa":"-24.91%","roe":"-55.77%","lyrEps":-9.657878,"shares":3743889,"dividePrice":0,"high":17.54,"amplitude":0,"preClose":17.54,"low":17.54,"week52Low":17.54,"pbRate":"5.70","week52High":17.54,"institutionHeld":0,"latestPrice":17.54,"eps":-2.9151,"divideRate":0,"volume":0,"delay":0,"ttmEps":-2.9151,"open":17.54,"prevYearClose":17.54,"prevWeekClose":17.54,"prevMonthClose":17.54,"prevQuarterClose":17.54,"fiveDayClose":17.54,"twentyDayClose":17.54,"sixtyDayClose":17.54},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/XBIOW\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-07-19","symbol":"XBIOW","reason":null,"defaultRemindTime":1721395800000,"announcedDate":"2024-07-18","type":"delisting","dateTimestamp":1721361600000},{"date":"2020-05-11","symbol":"XBIOW","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1589184000000,"name":null,"time":"Pre-Market","dateTimestamp":1589169600000,"actualEps":null},{"market":"US","date":"2019-08-16","symbol":"XBIOW","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1565928000000,"reportTimeType":"pre","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"XBIOW\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"XBIOW\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.xeneticbio.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":0.0066},{"period":"1month","weight":-0.0027},{"period":"3month","weight":0.0113},{"period":"6month","weight":0.0592},{"period":"1year","weight":0.1509},{"period":"ytd","weight":0.008}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Xenetic Biosciences, Inc., a biopharmaceutical company, focuses on advancing XCART, a personalized chimeric antigen receptor T cell (CAR T) platform technology engineered to target patient-specific tumor neoantigens. The company engages in the development of biologic drugs and therapeutics. It advances cell-based therapeutics targeting the B-cell receptor on the surface of an individual patient's malignant tumor cells for the treatment of B-cell lymphomas. In addition, the company leveraging PolyXen, its proprietary drug delivery platform, by partnering with biotechnology and pharmaceutical companies. It has collaboration agreements with Takeda Pharmaceutical Co. Ltd., Serum Institute of India Limited, and PJSC Pharmsynthez. Xenetic Biosciences, Inc. is headquartered in Framingham, Massachusetts.","yearOnYearQuotes":[{"month":1,"riseRate":0.142857,"avgChangeRate":0.051831},{"month":2,"riseRate":0.285714,"avgChangeRate":-0.076768},{"month":3,"riseRate":0.333333,"avgChangeRate":0.037492},{"month":4,"riseRate":0.5,"avgChangeRate":0.21428},{"month":5,"riseRate":0.333333,"avgChangeRate":1.570668},{"month":6,"riseRate":0.333333,"avgChangeRate":0.04636},{"month":7,"riseRate":0.666667,"avgChangeRate":0.32354},{"month":8,"riseRate":0.285714,"avgChangeRate":-0.011342},{"month":9,"riseRate":0.142857,"avgChangeRate":-0.077643},{"month":10,"riseRate":0.285714,"avgChangeRate":-0.210774},{"month":11,"riseRate":0.142857,"avgChangeRate":1.27528},{"month":12,"riseRate":0.571429,"avgChangeRate":238.414856}],"exchange":"NASDAQ","name":"Xenetic Biosciences Inc","nameEN":"Xenetic Biosciences Inc"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"XBIOW\",market:\"US\",,,undefined,":null}}